Title : Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report.

Pub. Date : 2022

PMID : 35070248






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BRCA-mutated patients, already treated with platinum-derived drugs, who suffered DNA damage, cannot repair the breaks due to lurbinectedin interaction, whereas irinotecan provokes a dsDNA break that promotes synthetic lethality. Platinum BRCA1 DNA repair associated Homo sapiens